Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kopetz

Showing results (31-40 of 457) with videos related to

Pageof 46
Sort By:
Lancet (London, England)|March 25, 2008
Perioperative chemotherapy for resectable hepatic metastasesScott Kopetz, Jean-Nicolas Vauthey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Tumor Microenvironment in Gene Signatures: Critical Biology or Confounding Noise?Jeffrey S Morris, Scott Kopetz
Clinical Colorectal Cancer|June 17, 2015
Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal CancerMichael S Lee, Scott Kopetz
Cell Research|January 16, 2023
EMP1<sup>+</sup> tumor cells drive metastatic relapseOscar E Villarreal, Scott Kopetz
Therapeutic Advances in Medical Oncology|August 11, 2017
Recent developments in the treatment of metastatic colorectal cancerJonathan M Loree, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Barriers to Integrating Gene Profiling for Stage II Colon CancerScott Kopetz, James L Abbruzzese
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Hurdles and complexities of codon 13 KRAS mutationsMaria Pia Morelli, Scott Kopetz
Journal of Gastrointestinal Oncology|December 24, 2015
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapiesCallisia N Clarke, E Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The promise of patient-derived xenografts: the best laid plans of mice and menScott Kopetz, Robert Lemos, Garth Powis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2023
Reply to Y. Yu et alKanwal Raghav, Scott Kopetz, Ying Yuan
Pageof 46

Showing results (31-40 of 457) with videos related to

Sort By:
Pageof 46
Lancet (London, England)|March 25, 2008
Perioperative chemotherapy for resectable hepatic metastasesScott Kopetz, Jean-Nicolas Vauthey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Tumor Microenvironment in Gene Signatures: Critical Biology or Confounding Noise?Jeffrey S Morris, Scott Kopetz
Clinical Colorectal Cancer|June 17, 2015
Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal CancerMichael S Lee, Scott Kopetz
Cell Research|January 16, 2023
EMP1<sup>+</sup> tumor cells drive metastatic relapseOscar E Villarreal, Scott Kopetz
Therapeutic Advances in Medical Oncology|August 11, 2017
Recent developments in the treatment of metastatic colorectal cancerJonathan M Loree, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Barriers to Integrating Gene Profiling for Stage II Colon CancerScott Kopetz, James L Abbruzzese
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Hurdles and complexities of codon 13 KRAS mutationsMaria Pia Morelli, Scott Kopetz
Journal of Gastrointestinal Oncology|December 24, 2015
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapiesCallisia N Clarke, E Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
The promise of patient-derived xenografts: the best laid plans of mice and menScott Kopetz, Robert Lemos, Garth Powis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2023
Reply to Y. Yu et alKanwal Raghav, Scott Kopetz, Ying Yuan
Pageof 46